News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
Bhavnagri Veer
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 06/29/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 03/16/2023 |
4
| Bhavnagri Veer (General Counsel) has filed a Form 4 on Allogene Therapeutics, Inc.|
Txns:
| Paid exercise price by delivering 23,628 shares
@ $5.67, valued at
$134k
|
|
| 02/14/2023 |
4
| Bhavnagri Veer (General Counsel) has filed a Form 4 on Allogene Therapeutics, Inc.|
Txns:
| Sold 3,000 shares
@ $6.85, valued at
$20.6k
|
|
| 01/18/2023 |
4
| Bhavnagri Veer (General Counsel) has filed a Form 4 on Allogene Therapeutics, Inc.|
Txns:
| Sold 3,000 shares
@ $7.04, valued at
$21.1k
|
|
| 12/19/2022 |
4
| Bhavnagri Veer (General Counsel) has filed a Form 4 on Allogene Therapeutics, Inc.|
Txns:
| Sold 5,602 shares
@ $7.5306, valued at
$42.2k
|
|
| 03/25/2022 |
4
| Bhavnagri Veer (General Counsel) has filed a Form 4 on Allogene Therapeutics, Inc.|
Txns:
| Granted 175,438 shares
@ $0
Granted 272,435 options to buy
@ $9.69, valued at
$2.6M
|
|
| 03/17/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 09/17/2021 |
4
| Bhavnagri Veer (General Counsel) has filed a Form 4 on Allogene Therapeutics, Inc.|
Txns:
| Sold 5,000 shares
@ $24.7689, valued at
$123.8k
Exercised 5,000 options to buy
@ $2.27, valued at
$11.4k
|
|
| 07/16/2021 |
4
| Bhavnagri Veer (General Counsel) has filed a Form 4 on Allogene Therapeutics, Inc.|
Txns:
| Sold 5,000 shares
@ $21.5506, valued at
$107.8k
Exercised 5,000 options to buy
@ $2.27, valued at
$11.4k
|
|
| 06/16/2021 |
4
| Bhavnagri Veer (General Counsel) has filed a Form 4 on Allogene Therapeutics, Inc.|
Txns:
| Sold 5,000 shares
@ $25.32, valued at
$126.6k
Exercised 5,000 options to buy
@ $2.27, valued at
$11.4k
|
|
| 05/20/2021 |
4
| Bhavnagri Veer (General Counsel) has filed a Form 4 on Allogene Therapeutics, Inc.|
Txns:
| Sold 5,000 shares
@ $30, valued at
$150k
Exercised 5,000 options to buy
@ $2.27, valued at
$11.4k
|
|
| 05/17/2021 |
4
| Bhavnagri Veer (General Counsel) has filed a Form 4 on Allogene Therapeutics, Inc.|
Txns:
| Sold 5,000 shares
@ $28.2951, valued at
$141.5k
Exercised 5,000 options to buy
@ $2.27, valued at
$11.4k
|
|
| 04/16/2021 |
4
| Bhavnagri Veer (General Counsel) has filed a Form 4 on Allogene Therapeutics, Inc.|
Txns:
| Sold 9,394 shares
@ $32.0138, valued at
$300.7k
Sold 606 shares
@ $32.6398, valued at
$19.8k
Exercised 10,000 options to buy
@ $2.27, valued at
$22.7k
|
|
| 03/17/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/18/2020 |
4
| Bhavnagri Veer (General Counsel) has filed a Form 4 on Allogene Therapeutics, Inc.|
Txns:
| Exercised 51,500 options to buy
@ $2.27, valued at
$116.9k
|
|
| 10/08/2020 |
4
| Bhavnagri Veer (General Counsel) has filed a Form 4 on Allogene Therapeutics, Inc.|
Txns:
| Sold 10,000 shares
@ $40, valued at
$400k
Exercised 10,000 options to buy
@ $2.27, valued at
$22.7k
|
|
| 10/02/2020 |
4
| Bhavnagri Veer (General Counsel) has filed a Form 4 on Allogene Therapeutics, Inc.|
Txns:
| Sold 16,215 shares
@ $36.2053, valued at
$587.1k
Sold 7,985 shares
@ $37.0274, valued at
$295.7k
Sold 800 shares
@ $37.725, valued at
$30.2k
Exercised 25,000 options to buy
@ $2.27, valued at
$56.8k
|
|
| 09/03/2020 |
4
| Bhavnagri Veer (General Counsel) has filed a Form 4 on Allogene Therapeutics, Inc.|
Txns:
| Sold 24,600 shares
@ $35.35, valued at
$869.6k
Sold 400 shares
@ $35.89, valued at
$14.4k
Exercised 25,000 options to buy
@ $2.27, valued at
$56.8k
|
|
| 08/05/2020 |
4
| Bhavnagri Veer (General Counsel) has filed a Form 4 on Allogene Therapeutics, Inc.|
Txns:
| Sold 15,103 shares
@ $36.4645, valued at
$550.7k
Sold 16,450 shares
@ $37.2886, valued at
$613.4k
Exercised 25,000 options to buy
@ $2.27, valued at
$56.8k
|
|
| 04/22/2020 |
3
| Bhavnagri Veer (General Counsel) has filed a Form 3 on Allogene Therapeutics, Inc. |
|
|